NeoSED: Neonatal Sepsis Early Detection System
NeoSED Team: Paola Donis, Joe Hakim, Daniel Huang, Gabriela Rodal, Tam Thanitcul, Yuan Hao Wong, Justin Yan, Yu Zhang
Advisors: Dr. Robert Allen, Dr. Elizabeth Crisofalo, Dr. Soumyadipta Acharya, Dr. Eric McCollum, Dr. Alain Labrique, Dr. Sridevi Sarma,
Dr. Nicholas Durr, Dr. Richard Hamilton
Implementation Pathway
Next steps:
-
Submission of IRB for prospective data collection of neonates’ vital signs at Johns Hopkins Hospital (Early Summer)
-
Begin collection of neonatal data at Johns Hopkins Hospital (late summer or when IRB approved)
-
Iteration of ML methods, algorithm development
-
Pilot testing of device efficacy with project partners in Bangladesh
Adoption pathway:
-
Preliminary small scale dissemination in Bangladesh, feedback collection and improve on device
-
Larger scale deployment in Bangladesh, possibly followed by India.
Regulatory classification:
-
FDA approval for a Class II device with predicate
IP protection plan:
-
Design patent for SepSock, utility patent for the SepScore system, copyright for the manual and a trademark

Fig 1: Potential target regions in India for dissemination

Fig 2: Potential partners specializing in global health initiatives